GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM80833
Query DataSets for GSM80833
Status
Public on Mar 30, 2006
Title
substantia_nigra_4
Sample type
RNA
Source name
substantia_nigra
Organism
Homo sapiens
Characteristics
Normal tissue
Extracted molecule
total RNA
Extraction protocol
Total RNA extracted using standard Trizol protocol, followed by Qiagen RNeasy column clean-up
Label
biotin
Label protocol
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
Hybridization protocol
standard Affymetrix procedures
Scan protocol
standard Affymetrix procedures
Description
substantia_nigra_4
Data processing
RMA
Submission date
Oct 28, 2005
Last update date
Aug 28, 2018
Contact name
Richard B Roth
E-mail(s)
rroth@neurocrine.com
Organization name
Neurocrine Biosciences, Inc.
Department
Molecular Medicine
Street address
12790 El Camino Real
City
San Diego
State/province
CA
ZIP/Postal code
92130
Country
USA
Platform ID
GPL570
Series (1)
GSE3526
Comparison of gene expression profiles across the normal human body
Relations
Reanalyzed by
GSE64985
Reanalyzed by
GSE119087
Data table header descriptions
ID_REF
Affymetrix U133 plus 2.0 array
VALUE
RMA
Data table
ID_REF
VALUE
1007_s_at
842.736
1053_at
33.411476
117_at
56.641758
121_at
231.25677
1255_g_at
20.03402
1294_at
115.14228
1316_at
96.33278
1320_at
37.876244
1405_i_at
21.615307
1431_at
28.93939
1438_at
115.07691
1487_at
125.04943
1494_f_at
99.273384
1552256_a_at
282.5232
1552257_a_at
108.55923
1552258_at
45.911057
1552261_at
47.04392
1552263_at
16.605934
1552264_a_at
62.359764
1552266_at
21.216648
Total number of rows:
54613
Table truncated, full table size
1089 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM80833.CEL.gz
7.4 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
